Boston Scientific (BSX) closed at $44.14 in the latest trading session, marking a +2.65% move from the prior day.
Boston Scientific (BSX) reached $42.73 at the closing of the latest trading day, reflecting a +1.64% change compared to its last close.
Boston Scientific (BSX) concluded the recent trading session at $42.04, signifying a +1.11% move from its prior day's close.
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| TJD Thomas John Drogan PR Inc.IPAL SECURITIES Inc. | 41,257 | $3.03M | $1.82M | -$1.21M | -39.83% |
| DI David Izzi Brown, LISLE/CUMMINGS Inc. | 77,778 | $3.6M | $3.45M | -$149,887.98 | -4.16% |
Timothy M. Bidwell Hazlett, BURT & WATSON Inc. | 1,411 | $90,352.14 | $62,563.74 | -$27,788.4 | -30.76% |
| LC Lisa Candera CIGNA INVESTMENTS Inc. /NEW | 14,027 | $508,133.93 | $619,151.78 | $111,017.85 | 21.85% |
Curtis Ellergodt Rothschild Investment LLC | 50,129 | $2.43M | $2.21M | -$215,336.93 | -8.87% |
| Health Care Equipment & Supplies Industry | Healthcare Sector | Michael F. Mahoney CEO | NYSE Exchange | 101137107 CUSIP |
| US Country | 59,000 Employees | - Last Dividend | 6 Nov 2003 Last Split | 18 May 1992 IPO Date |
Boston Scientific Corporation is a global developer, manufacturer, and marketer of medical devices used in a variety of interventional medical specialties. Having begun its operations in 1979, the company has grown to serve a diverse range of medical needs through its two primary segments: MedSurg and Cardiovascular. With its headquarters in Marlborough, Massachusetts, Boston Scientific is committed to improving patient health by providing cutting-edge solutions that address complex medical conditions and enhance the quality of life for patients worldwide.